300 years of Andrew Witty? What to buy with $3 billion
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline, part of what used to be called 'the ethical pharmaceutical industry' back in the days when Boy Scouts wore short pants, was docked a record $3 billion in state and federal fines and in liabilities in the US for misdemeanours violations concerning the marketing of antidepressants and its diabetes drug, Avandia (scripintelligence.com, 3 July 2012).